NO20070334L - 4,6-disubstituerte pyrimidiner og deres anvendelse som proteinkinaseinhibitorer - Google Patents
4,6-disubstituerte pyrimidiner og deres anvendelse som proteinkinaseinhibitorerInfo
- Publication number
- NO20070334L NO20070334L NO20070334A NO20070334A NO20070334L NO 20070334 L NO20070334 L NO 20070334L NO 20070334 A NO20070334 A NO 20070334A NO 20070334 A NO20070334 A NO 20070334A NO 20070334 L NO20070334 L NO 20070334L
- Authority
- NO
- Norway
- Prior art keywords
- protein kinase
- kinase inhibitors
- disubstituted pyrimidines
- pyrimidines
- disubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Oppfinnelsen vedrører nye pyrimidinderivater med formel (I), som er effektive proteinkinaserinhibitorer, spesielt av én eller flere isoformer av proteinkinasen B/Akt. ?? ?? ?? ??
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04103011 | 2004-06-28 | ||
EP05102355 | 2005-03-23 | ||
PCT/EP2005/053019 WO2006000589A1 (en) | 2004-06-28 | 2005-06-28 | 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20070334L true NO20070334L (no) | 2007-03-28 |
Family
ID=34973043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20070334A NO20070334L (no) | 2004-06-28 | 2007-01-18 | 4,6-disubstituerte pyrimidiner og deres anvendelse som proteinkinaseinhibitorer |
Country Status (16)
Country | Link |
---|---|
US (1) | US7879853B2 (no) |
EP (1) | EP1763526B1 (no) |
JP (1) | JP5065017B2 (no) |
KR (1) | KR20070027723A (no) |
CN (1) | CN1972934A (no) |
AT (1) | ATE434614T1 (no) |
AU (1) | AU2005256659A1 (no) |
BR (1) | BRPI0512547A (no) |
CA (1) | CA2570552A1 (no) |
DE (1) | DE602005015110D1 (no) |
ES (1) | ES2328601T3 (no) |
IL (1) | IL179883A0 (no) |
MX (1) | MXPA06014747A (no) |
NO (1) | NO20070334L (no) |
WO (1) | WO2006000589A1 (no) |
ZA (1) | ZA200609637B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6907921B2 (en) | 1998-06-18 | 2005-06-21 | 3M Innovative Properties Company | Microchanneled active fluid heat exchanger |
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
MY147628A (en) | 2006-07-06 | 2012-12-31 | Array Biopharma Inc | Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
JP2010505962A (ja) | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
US20090012434A1 (en) * | 2007-07-03 | 2009-01-08 | Anderson Robert S | Apparatus, method, and system to treat a volume of skin |
EP2214486A4 (en) * | 2007-10-19 | 2011-03-09 | Avila Therapeutics Inc | HETEROARYL COMPOUNDS AND ITS USES |
SG194048A1 (en) | 2011-04-01 | 2013-11-29 | Genentech Inc | Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use |
CN103841976A (zh) | 2011-04-01 | 2014-06-04 | 基因泰克公司 | Akt和mek抑制剂化合物的组合及其使用方法 |
AU2012321091B2 (en) * | 2011-10-28 | 2016-05-12 | Celgene Avilomics Research, Inc. | Methods of treating a Bruton's Tyrosine Kinase disease or disorder |
US9364476B2 (en) * | 2011-10-28 | 2016-06-14 | Celgene Avilomics Research, Inc. | Methods of treating a Bruton's Tyrosine Kinase disease or disorder |
MA37472A1 (fr) * | 2012-04-04 | 2016-09-30 | Amgen Inc | Composés hétérocycliques et leurs utilisations |
US9145387B2 (en) | 2013-02-08 | 2015-09-29 | Celgene Avilomics Research, Inc. | ERK inhibitors and uses thereof |
CN105764501A (zh) | 2013-07-26 | 2016-07-13 | 现代化制药公司 | 改善比生群治疗效益的组合物 |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
CN103601675B (zh) * | 2013-10-08 | 2015-10-28 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
CN103483250B (zh) * | 2013-10-08 | 2015-07-22 | 南京复兴生物科技有限公司 | 一种5-氨甲基烟酸的制备方法 |
US10005760B2 (en) | 2014-08-13 | 2018-06-26 | Celgene Car Llc | Forms and compositions of an ERK inhibitor |
CN113509471B (zh) * | 2021-07-19 | 2023-06-13 | 中国药科大学 | Akt2抑制剂在制备治疗阿霉素引发心肌损伤药物中的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW321649B (no) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
ZA986732B (en) | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitiors of tyrosine kinases |
CN1280580A (zh) | 1997-11-11 | 2001-01-17 | 辉瑞产品公司 | 用作抗癌药的噻吩并嘧啶和噻吩并吡啶衍生物 |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
EP1246823A1 (en) * | 1999-12-28 | 2002-10-09 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
US20020065270A1 (en) * | 1999-12-28 | 2002-05-30 | Moriarty Kevin Joseph | N-heterocyclic inhibitors of TNF-alpha expression |
BR0113165A (pt) | 2000-08-08 | 2003-07-15 | Ortho Mcneil Pharm Inc | Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados |
AR035967A1 (es) * | 2001-05-18 | 2004-07-28 | Altana Pharma Ag | Un compuesto de piridilmetilaminopirimidina, un medicamento que lo comprende y el uso del mismo |
US7183288B2 (en) | 2001-11-01 | 2007-02-27 | Herwig Josephus Margareta Janssen, legal representative | Amide derivatives as glycogen synthase kinase 3-β inhibitors |
EP1448556A1 (en) * | 2001-11-01 | 2004-08-25 | Janssen Pharmaceutica N.V. | Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors) |
US20030187026A1 (en) * | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
US7910586B2 (en) | 2002-01-04 | 2011-03-22 | The Rockefeller University | Compositions and methods for prevention and treatment of amyloid-β peptide-related disorders |
AU2003295776B2 (en) | 2002-11-21 | 2011-05-12 | Novartis Vaccines And Diagnostics, Inc. | 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer |
EP1678147B1 (en) | 2003-09-15 | 2012-08-08 | Lead Discovery Center GmbH | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
EP1709007A1 (en) | 2004-01-22 | 2006-10-11 | Altana Pharma AG | N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors |
EP1901747A2 (en) * | 2005-05-25 | 2008-03-26 | Ingenium Pharmaceuticals AG | Pyrimidine-based cdk inhibitors for treating pain |
-
2005
- 2005-06-28 JP JP2007517306A patent/JP5065017B2/ja not_active Expired - Fee Related
- 2005-06-28 KR KR1020077001451A patent/KR20070027723A/ko not_active Application Discontinuation
- 2005-06-28 BR BRPI0512547-2A patent/BRPI0512547A/pt not_active IP Right Cessation
- 2005-06-28 US US11/630,352 patent/US7879853B2/en not_active Expired - Fee Related
- 2005-06-28 MX MXPA06014747A patent/MXPA06014747A/es not_active Application Discontinuation
- 2005-06-28 DE DE602005015110T patent/DE602005015110D1/de active Active
- 2005-06-28 EP EP05769611A patent/EP1763526B1/en active Active
- 2005-06-28 AT AT05769611T patent/ATE434614T1/de not_active IP Right Cessation
- 2005-06-28 WO PCT/EP2005/053019 patent/WO2006000589A1/en active Application Filing
- 2005-06-28 CN CNA2005800205458A patent/CN1972934A/zh active Pending
- 2005-06-28 AU AU2005256659A patent/AU2005256659A1/en not_active Abandoned
- 2005-06-28 CA CA002570552A patent/CA2570552A1/en not_active Abandoned
- 2005-06-28 ES ES05769611T patent/ES2328601T3/es active Active
-
2006
- 2006-11-20 ZA ZA200609637A patent/ZA200609637B/xx unknown
- 2006-12-06 IL IL179883A patent/IL179883A0/en unknown
-
2007
- 2007-01-18 NO NO20070334A patent/NO20070334L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE602005015110D1 (de) | 2009-08-06 |
EP1763526A1 (en) | 2007-03-21 |
JP5065017B2 (ja) | 2012-10-31 |
US20070208034A1 (en) | 2007-09-06 |
MXPA06014747A (es) | 2007-02-16 |
WO2006000589A8 (en) | 2006-11-16 |
JP2008504251A (ja) | 2008-02-14 |
BRPI0512547A (pt) | 2008-03-25 |
ES2328601T3 (es) | 2009-11-16 |
US7879853B2 (en) | 2011-02-01 |
CN1972934A (zh) | 2007-05-30 |
IL179883A0 (en) | 2007-05-15 |
WO2006000589A1 (en) | 2006-01-05 |
EP1763526B1 (en) | 2009-06-24 |
KR20070027723A (ko) | 2007-03-09 |
CA2570552A1 (en) | 2006-01-05 |
AU2005256659A1 (en) | 2006-01-05 |
ZA200609637B (en) | 2008-08-27 |
ATE434614T1 (de) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070334L (no) | 4,6-disubstituerte pyrimidiner og deres anvendelse som proteinkinaseinhibitorer | |
NO20074431L (no) | Pyrrolopyrimidiner nyttige som proteinkinaseinhibitorer | |
DK1567522T3 (da) | Pyrimidinforbindelser | |
NO20082508L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
WO2005116025A3 (en) | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders | |
NO20081893L (no) | 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft | |
NO20070526L (no) | Kinazolindionderivater som parp-inhibitorer | |
ATE466580T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE468336T1 (de) | Azolylaminoazine als proteinkinasehemmer | |
ATE365733T1 (de) | Zusammensetzungen brauchbar als protein-kinase- inhibitoren | |
NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
NO20072567L (no) | Triazoler nyttige som proteinkinase-inhibitorer | |
NO20065727L (no) | Pyrrolinhibitorer av erk-proteinkinase, syntese derav og deres mellomprodukter | |
WO2007079164A3 (en) | Protein kinase inhibitors | |
NO20076502L (no) | Pyrrolopyridiner nyttige som inhibitorer av proteinkinase | |
DK1791830T3 (da) | Diaminotriazol-forbindelser der er nyttige som protein-kinase-inhibitorer | |
ATE474835T1 (de) | Als inhibitoren von proteinkinasen geeignete aminopyrimidine | |
NO20070532L (no) | Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer | |
NO20064976L (no) | Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser | |
DK1483265T3 (da) | Purinderivater som kinaseinhibitorer | |
WO2006083673A3 (en) | Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases | |
ATE508126T1 (de) | Als kinaseinhibitoren geeignete aminopyrimidine | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
BRPI0509369A (pt) | azaindóis úteis como inibidores de jak e outras proteìna cinases | |
ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104 |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |